A detailed history of Campbell & CO Investment Adviser LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 3,690 shares of LGND stock, worth $418,372. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,690
Previous 4,761 22.5%
Holding current value
$418,372
Previous $348,000 10.92%
% of portfolio
0.03%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$68.53 - $87.91 $73,395 - $94,151
-1,071 Reduced 22.5%
3,690 $310,000
Q1 2024

May 10, 2024

SELL
$68.64 - $89.2 $193,564 - $251,544
-2,820 Reduced 37.2%
4,761 $348,000
Q4 2023

Feb 13, 2024

BUY
$49.57 - $72.63 $120,702 - $176,854
2,435 Added 47.32%
7,581 $541,000
Q3 2023

Nov 08, 2023

BUY
$58.86 - $72.67 $36,375 - $44,910
618 Added 13.65%
5,146 $308,000
Q2 2023

Aug 11, 2023

BUY
$69.53 - $79.33 $10,499 - $11,978
151 Added 3.45%
4,528 $326,000
Q1 2023

May 11, 2023

SELL
$65.67 - $77.08 $52,338 - $61,432
-797 Reduced 15.4%
4,377 $321,000
Q4 2022

Feb 14, 2023

BUY
$61.72 - $96.74 $319,339 - $500,532
5,174 New
5,174 $345,000
Q1 2019

May 10, 2019

SELL
$105.93 - $142.47 $162,708 - $218,833
-1,536 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$128.36 - $272.13 $197,160 - $417,991
1,536 New
1,536 $231,000
Q2 2018

Jul 13, 2018

SELL
$150.77 - $207.98 $256,158 - $353,358
-1,699 Closed
0 $0
Q1 2018

May 04, 2018

BUY
$138.63 - $182.62 $235,532 - $310,271
1,699 New
1,699 $281,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.